Código QR (código de barras bidimensional)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma

BackgroundLung adenocarcinoma (LUAD) is the most common pathological type of lung cancer, with high incidence and mortality. To improve the curative effect and prolong the survival of patients, it is necessary to find new biomarkers to accurately predict the prognosis of patients and explore new str...

ver descrição completa

Na minha lista:
Principais autores: Yang Cheng, Kezuo Hou, Yizhe Wang, Yang Chen, Xueying Zheng, Jianfei Qi, Bowen Yang, Shiying Tang, Xu Han, Dongyao Shi, Ximing Wang, Yunpeng Liu, Xuejun Hu, Xiaofang Che
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021-06-01
coleção:Frontiers in Oncology
Assuntos:
lung adenocarcinoma
prognosis
signature
drug repositioning
gliclazide
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fonc.2021.665276/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados